HDAC-3 Antibody

<strong>HDAC-3 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015586_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> HDAC-3 Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis Autoimmunity. 2009 Feb;42(2):120-5._x000D_ 2: Munkhjargal T, Aboulaila M, Ueno A, Sivakumar T, Nakano Y, Yokoyama M, Yokoyama N, Igarashi I. Cloning and characterization of histone deacetylase from Babesia bovis Vet Parasitol. 2012 Dec 21;190(3-4):423-33._x000D_ 3: Bartling B, Hofmann HS, Boettger T, Hansen G, Burdach S, Silber RE, Simm A. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma Lung Cancer. 2005 Aug;49(2):145-54._x000D_ 4: Pooladanda V, Thatikonda S, Bale S, Pattnaik B, Sigalapalli DK, Bathini NB, Singh SB, Godugu C. Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation Cell Death Dis. 2019 Jan 28;10(2):81._x000D_ 5: Leus NG, Zwinderman MR, Dekker FJ. Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation Curr Opin Chem Biol. 2016 Aug;33:160-8._x000D_ 6: Leus NG, van der Wouden PE, van den Bosch T, Hooghiemstra WTR, Ourailidou ME, Kistemaker LE, Bischoff R, Gosens R, Haisma HJ, Dekker FJ. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity Biochem Pharmacol. 2016 May 15;108:58-74._x000D_ 7: Rahbari R, Rasmi Y, Khadem-Ansari MH, Abdi M. The role of histone deacetylase 3 in breast cancer Med Oncol. 2022 May 17;39(5):84._x000D_ 8: Soumyanarayanan U, Ramanujulu PM, Mustafa N, Haider S, Fang Nee AH, Tong JX, Tan KSW, Chng WJ, Dymock BW. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor Eur J Med Chem. 2019 Dec 15;184:111755._x000D_ 9: Panteleeva I, Rouaux C, Larmet Y, Boutillier S, Loeffler JP, Boutillier AL. HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons Ann N Y Acad Sci. 2004 Dec;1030:656-60._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/22375794">10: Kirpich I, Ghare S, Zhang J, Gobejishvili L, Kharebava G, Barve SJ, Barker D, Moghe A, McClain CJ, Barve S. Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3 Alcohol Clin Exp Res. 2012 Sep;36(9):1578-86. </a>_x000D_ _x000D_ <strong>Products Related to HDAC-3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>